CI-750, A novel antidiarrheal agent.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003967:Diarrhea / Q000188:drug therapy*; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D004347:Drug Interactions; D004361:Drug Tolerance; D004987:Ethers / Q000627:therapeutic use / Q000633:toxicity; D005021:Ethylamines / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D005243:Feces / Q000187:drug effects; D005765:Gastrointestinal Agents / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D007422:Intestines / Q000187:drug effects; D008297:Male; D009020:Morphine / Q000627:therapeutic use; D009270:Naloxone; D051381:Rats; D013270:Stomach / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D013997:Time Factors
D004987:Ethers; D005021:Ethylamines; D005765:Gastrointestinal Agents; D007211:Indoles; D009270:Naloxone; C005164:CI 750; D009020:Morphine